| Dr Cade J Burns, MD | |
|
301 4th St Ste 3h, Alexandria, LA 71301-8411 | |
| (318) 441-1041 | |
| (318) 441-1050 |
| Full Name | Dr Cade J Burns |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 2 Years |
| Location | 301 4th St Ste 3h, Alexandria, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750919304 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Oakdale Community Hospital | Oakdale, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clhg-oakdale Llc | 1355623943 | 24 |
| Leatherwood Emergency Group Llc | 0749521250 | 13 |
News Archive
Over 300,000 immigrants a year are detained by United States Immigration and Customs Enforcement (USICE), a branch of the Department of Homeland Security. These immigrants are held at facilities run by, or under contract with, USICE. In recent years, studies by community-based organizations, the government, and the media have identified systemic deficiencies in the provision of healthcare to immigrant detainees and have described incidents of inadequate medical treatment, suffering and, in some cases, death.
Researchers have shown that a novel delivery strategy can efficiently introduce a functional microRNA that has anti-cancer and angiogenic activities into two different types of cells-breast cancer cells to inhibit tumor growth and metastasis, and cells that line blood vessels to protect against atherosclerosis.
AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).
Today's headlines include details of an extensive, nationwide audit of the wait times for care at VA hospitals and clinics.
› Verified 2 days ago
| Entity Name | Clhg-oakdale Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063111920 PECOS PAC ID: 1355623943 Enrollment ID: O20181116002285 |
News Archive
Over 300,000 immigrants a year are detained by United States Immigration and Customs Enforcement (USICE), a branch of the Department of Homeland Security. These immigrants are held at facilities run by, or under contract with, USICE. In recent years, studies by community-based organizations, the government, and the media have identified systemic deficiencies in the provision of healthcare to immigrant detainees and have described incidents of inadequate medical treatment, suffering and, in some cases, death.
Researchers have shown that a novel delivery strategy can efficiently introduce a functional microRNA that has anti-cancer and angiogenic activities into two different types of cells-breast cancer cells to inhibit tumor growth and metastasis, and cells that line blood vessels to protect against atherosclerosis.
AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).
Today's headlines include details of an extensive, nationwide audit of the wait times for care at VA hospitals and clinics.
› Verified 2 days ago
| Entity Name | Leatherwood Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760946313 PECOS PAC ID: 0749521250 Enrollment ID: O20190410002335 |
News Archive
Over 300,000 immigrants a year are detained by United States Immigration and Customs Enforcement (USICE), a branch of the Department of Homeland Security. These immigrants are held at facilities run by, or under contract with, USICE. In recent years, studies by community-based organizations, the government, and the media have identified systemic deficiencies in the provision of healthcare to immigrant detainees and have described incidents of inadequate medical treatment, suffering and, in some cases, death.
Researchers have shown that a novel delivery strategy can efficiently introduce a functional microRNA that has anti-cancer and angiogenic activities into two different types of cells-breast cancer cells to inhibit tumor growth and metastasis, and cells that line blood vessels to protect against atherosclerosis.
AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).
Today's headlines include details of an extensive, nationwide audit of the wait times for care at VA hospitals and clinics.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cade J Burns, MD 301 4th St Ste 3h, Alexandria, LA 71301-8411 Ph: (318) 441-1041 | Dr Cade J Burns, MD 301 4th St Ste 3h, Alexandria, LA 71301-8411 Ph: (318) 441-1041 |
News Archive
Over 300,000 immigrants a year are detained by United States Immigration and Customs Enforcement (USICE), a branch of the Department of Homeland Security. These immigrants are held at facilities run by, or under contract with, USICE. In recent years, studies by community-based organizations, the government, and the media have identified systemic deficiencies in the provision of healthcare to immigrant detainees and have described incidents of inadequate medical treatment, suffering and, in some cases, death.
Researchers have shown that a novel delivery strategy can efficiently introduce a functional microRNA that has anti-cancer and angiogenic activities into two different types of cells-breast cancer cells to inhibit tumor growth and metastasis, and cells that line blood vessels to protect against atherosclerosis.
AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).
Today's headlines include details of an extensive, nationwide audit of the wait times for care at VA hospitals and clinics.
› Verified 2 days ago
Dr. Robert W Moore, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 Pecan Park Ave, Alexandria, LA 71303 Phone: 318-442-1002 Fax: 318-442-1008 | |
Robert Larimer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 4th Street, Rapides Regional Medical Center, Alexandria, LA 71301 Phone: 318-473-3000 | |
Ifedolapo Sulyman Olanrewaju, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3330 Masonic Dr, Alexandria, LA 71301 Phone: 318-487-1122 Fax: 318-449-2320 | |
Michael Gurdon Buck, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1587 N Bolton Ave, Suite 1100, Alexandria, LA 71303 Phone: 318-473-4500 Fax: 318-445-1509 | |
Dr. Margo Lashae Thomas, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3335 Prescott Rd, Alexandria, LA 71301 Phone: 318-442-5758 | |
Ashley Billings, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 6507 Coliseum Blvd, Alexandria, LA 71303 Phone: 318-483-7774 | |
Jane Anjul Singh, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Versailles Blvd Ste D, Alexandria, LA 71303 Phone: 318-528-3200 |